NCT07317674

Brief Summary

Labor induction rates have increased substantially worldwide, and successful cervical ripening remains a key determinant of induction outcomes. Mechanical cervical ripening with a Foley balloon catheter is widely used and considered safe, while nipple stimulation promotes endogenous oxytocin release and represents a physiologic method for stimulating uterine contractions. However, the combined effect of nipple stimulation and balloon catheter use has not been systematically evaluated. This prospective, randomized, double-blinded controlled trial will assess whether the addition of nipple stimulation to Foley balloon catheter cervical ripening improves Bishop score and shortens the induction-to-delivery interval compared with balloon catheter alone. Term pregnant patients (37-42 weeks' gestation) with a singleton, cephalic pregnancy and an unfavorable cervix (Bishop score \<6) requiring labor induction will be randomized to receive either Foley balloon catheter plus standardized nipple stimulation or Foley balloon catheter alone. The primary outcomes are change in Bishop score after catheter removal and time from catheter insertion to delivery. Secondary outcomes include need for additional induction methods, mode of delivery, maternal and neonatal outcomes, pain, patient satisfaction, and breastfeeding rates. The study aims to evaluate the efficacy and safety of incorporating a physiologic intervention into standard mechanical cervical ripening.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jan 2026Jan 2028

First Submitted

Initial submission to the registry

December 19, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 19, 2025

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Induction-to-delivery interval

    Defined as the time (in hours) from Foley balloon catheter insertion until delivery.

    From Foley balloon catheter insertion until delivery (up to 48 hours)

  • Change in Bishop score

    Defined as the difference between the Bishop score before Foley balloon catheter insertion and after catheter removal.

    From Foley balloon catheter insertion until catheter removal (up to 12 hours)

Study Arms (2)

Foley Balloon Catheter Combined With Nipple Stimulation

EXPERIMENTAL

Participants in this arm will undergo cervical ripening using a single-balloon Foley catheter. One hour after catheter insertion, nipple stimulation will be initiated using a breast pump according to a standardized protocol (15 minutes per breast, alternating with 15-minute rest periods, for up to 6 hours or until active labor, membrane rupture, uterine tachysystole, or non-reassuring fetal heart rate occurs).

Procedure: Foley balloon catheter with nipple stimulation

Foley Balloon Catheter Alone

ACTIVE COMPARATOR

Participants in this arm will undergo cervical ripening using a single-balloon Foley catheter alone, without nipple stimulation. Labor management following catheter insertion and removal will follow standard institutional protocols.

Procedure: Mechanical cervical ripening with Foley catheter

Interventions

Mechanical cervical ripening will be performed using a single-balloon Foley catheter inserted transcervically under sterile conditions. The catheter balloon will be positioned above the internal cervical os and inflated with 60 mL of sterile saline solution. The catheter will remain in place for up to 12 hours or until spontaneous expulsion, onset of active labor, rupture of membranes, uterine tachysystole, or non-reassuring fetal heart rate tracing, whichever occurs first. In participants randomized to the intervention arm, cervical ripening with the Foley catheter will be combined with nipple stimulation using an electric breast pump according to a standardized protocol, beginning one hour after catheter insertion. Participants in the control arm will undergo cervical ripening with the Foley catheter alone, without nipple stimulation. Cervical status will be assessed before catheter insertion and after catheter removal using the Bishop score. Subsequent labor management will follow

Foley Balloon Catheter Combined With Nipple Stimulation

Mechanical cervical ripening will be performed using a single-balloon Foley catheter inserted transcervically under sterile conditions. The catheter balloon will be positioned above the internal cervical os and inflated with 60 mL of sterile saline solution. The catheter will remain in place for up to 12 hours or until spontaneous expulsion, onset of active labor, rupture of membranes, uterine tachysystole, or non-reassuring fetal heart rate tracing, whichever occurs first.

Foley Balloon Catheter Alone

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study is open to individuals who self-identify as female and are pregnant.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant individuals aged ≥18 years
  • Singleton pregnancy
  • Term gestation (37-42 weeks)
  • Cephalic fetal presentation
  • Intact membranes
  • Bishop score \<6 at enrollment
  • Medical indication for labor induction

You may not qualify if:

  • Multiple gestation
  • Previous cesarean delivery or uterine surgery
  • Contraindication to vaginal delivery
  • Major fetal anomalies
  • Active labor at enrollment
  • Unstable fetal lie or presentation
  • Contraindication to Foley balloon catheter insertion
  • Conditions precluding nipple stimulation (e.g., local breast infection, prior breast surgery involving the nipple)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Kavanagh J, Kelly AJ, Thomas J. Breast stimulation for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD003392. doi: 10.1002/14651858.CD003392.pub2.

  • Abu Shqara R, Goldinfeld G, Assulyn T, Sgayer I, Ganem N, Lowenstein L, Frank Wolf M. Breast stimulation vs low dose oxytocin for labor augmentation in women with a previous cesarean delivery, a randomized controlled trial. Am J Obstet Gynecol MFM. 2025 May;7(5):101658. doi: 10.1016/j.ajogmf.2025.101658. Epub 2025 Mar 5.

  • de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2019 Oct 18;10(10):CD001233. doi: 10.1002/14651858.CD001233.pub3.

Study Officials

  • Maya Frank Wolf, Prof.

    Galilee Medical Center

    STUDY CHAIR

Central Study Contacts

Maya Frank Wolf Frank Wolf, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of MFMU

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 5, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

January 5, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared. De-identified aggregate data may be presented in scientific publications and presentations in accordance with institutional policies and ethical approvals.